Please assess the completion status of the following clinical trial:

Trial Title: The Effects of Milk Proteins on Blood Pressure

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: CROSSOVER
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: DOUBLE
- Phase: None
- Number of Arms: None

Eligibility Criteria:
Inclusion Criteria:~* Healthy female and male Caucasians~* Age between 30 and 70 years at Day 01 of the study~* Body Mass Index (BMI) 18 - 32 kg/m2~* Blood pressure: SBP 120-139 mmHg/DBP 80-89 mmHg (pre-hypertension) or SBP 140-159/DBP 90-99 mmHg (stage 1 hypertension)~* Voluntary participation~* Having given their written informed consent~* Willing to accept use of all nameless data, including publication, and the confidential use and storage of all data for at least 15 years~* Willing to accept the disclosure of the financial benefit of participation in the study to the authorities concerned~Exclusion Criteria:~* Having a history of medical or surgical events that may significantly affect the study outcome, including cardiovascular disease or systolic blood pressure ≥ 160 mm Hg after repeated measurements~* Any concomitant medication, with the exception of paracetamol, that may influence the outcome of the study~* Intolerance or allergy to milk products~* Not willing to give up consumption of \>1 fermented dairy product per day~* Alcohol consumption \> 28 units/week for males or \> 21 units/week for females women)~* Smoking~* Reported unexplained weight loss or weight gain of \> 2 kg in the month prior to pre-study screening or during the study~* Reported slimming or medically prescribed diet~* Reported vegan, vegetarian or macrobiotic life-style~* Participation in night shift work~* Pregnant or lactating or wishing to became pregnant in the period of the study~* Not having a general practitioner~* Not willing to accept information-transfer concerning participation in the study, or information regarding a subject's health to and from a subject's general practitioner.

- Gender: ALL
- Minimum Age: 30 Years
- Maximum Age: 70 Years
- Healthy Volunteers: t

Based on this trial design, predict the completion outcome and termination type (if applicable).